Aprea Therapeutics
APRE
APRE
26 hedge funds and large institutions have $6.83M invested in Aprea Therapeutics in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.33% more ownership
Funds ownership: 36.85% → 38.19% (+1.3%)
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$116K | |
| 2 | +$52.8K | |
| 3 | +$42.7K | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$39.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$19.5K |
Top Sellers
| 1 | -$30.2K | |
| 2 | -$4.38K | |
| 3 | -$2K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$165 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$3 |